Page 17 - Nuclear Export News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Redwood Wealth Management Group LLC acquired a new position in shares of Karyopharm Therapeutics Inc. (NASDAQ:KPTI – Get Rating) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 33,230 shares of the company’s stock, valued at approximately $113,000. Other hedge funds and other […]

/PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced it...

Several Westminster College honors students will publicly defend their capstone research projects this spring, marking the end of nearly two years of high-level academic exploration. 

Karyopharm Therapeutics Inc. (NASDAQ:KPTI – Get Rating) CEO Richard A. Paulson sold 3,497 shares of the company’s stock in a transaction dated Tuesday, April 4th. The stock was sold at an average price of $3.97, for a total transaction of $13,883.09. Following the completion of the transaction, the chief executive officer now owns 816,619 shares […]

NEWTON, Mass., April 3, 2023 /PRNewswire/ -- Karyopharm Therapeutics Inc. , a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the Company granted an... | April 3, 2023